New treatment option for postmenopausal women with non-invasive breast cancer

[News]

Anastrozole provides a significant benefit compared with tamoxifen in preventing recurrence after a lumpectomy and radiation therapy in postmenopausal women ages 60 years or younger who had DCIS (ductal carcinoma in situ), a common diagnosis of non-invasive breast cancer. In women over age 60, it works as well as tamoxifen.

More... (http://www.news-medical.net/news/20150602/New-treatment-option-for-postmenopausal-women-with-non-invasive-breast-cancer.aspx)